A phase II study of liposomal irinotecan-based chemotherapy with or without PD-1 inhibitor in patients with unresectable locally advanced or metastatic biliary tract cancer.Jieer Ying, Jing Yuan, Qi Xu et al.|Journal of Clinical Oncology|2024Cited by 0